We highly value customer testimonials and are grateful for the time customers take to provide these. The testimonials reflect the trust, collaboration, and scientific excellence that define our partnerships.
Recently Dr Dinah Misner, VP at Aligos Therapeutics, has taken time to summarise her experience of working with Metrion:
Metrion was recommended to Aligos in 2018 when we were looking for a lab to conduct routine hERG screening.
Aligos values the consistency and convenience of working with Metrion. The data is always correct and is in a format that imports directly into our systems, making it so quick and easy for our team to review the data across individual projects. Metrion are always on top of the regulations as they change – they were incredibly helpful in supporting us navigate the ICH changes a while ago.
At Aligos, we have used hERG, NaV1.5, and CaV1.2 screening routinely. Additionally, we have conducted long-term incubation with cardiomyocytes and measured functional endpoints for selected compounds where appropriate.
I have no hesitation in recommending Metrion as a CRO for preclinical drug discovery. Everyone in the Metrion team has been a pleasure to work with – I couldn’t think of anything I would change or improve about the way they work.
Read more testimonials from Metrion customers.
We highly value customer testimonials and are grateful for the time customers take to provide these. The testimonials reflect the trust, collaboration, and scientific excellence that define our partnerships.
Recently Dr Dinah Misner, VP at Aligos Therapeutics, has taken time to summarise her experience of working with Metrion:
Metrion was recommended to Aligos in 2018 when we were looking for a lab to conduct routine hERG screening.
Aligos values the consistency and convenience of working with Metrion. The data is always correct and is in a format that imports directly into our systems, making it so quick and easy for our team to review the data across individual projects. Metrion are always on top of the regulations as they change – they were incredibly helpful in supporting us navigate the ICH changes a while ago.
At Aligos, we have used hERG, NaV1.5, and CaV1.2 screening routinely. Additionally, we have conducted long-term incubation with cardiomyocytes and measured functional endpoints for selected compounds where appropriate.
I have no hesitation in recommending Metrion as a CRO for preclinical drug discovery. Everyone in the Metrion team has been a pleasure to work with – I couldn’t think of anything I would change or improve about the way they work.
Read more testimonials from Metrion customers.
We highly value customer testimonials and are grateful for the time customers take to provide these. The testimonials reflect the trust, collaboration, and scientific excellence that define our partnerships.
Recently Dr Dinah Misner, VP at Aligos Therapeutics, has taken time to summarise her experience of working with Metrion:
Metrion was recommended to Aligos in 2018 when we were looking for a lab to conduct routine hERG screening.
Aligos values the consistency and convenience of working with Metrion. The data is always correct and is in a format that imports directly into our systems, making it so quick and easy for our team to review the data across individual projects. Metrion are always on top of the regulations as they change – they were incredibly helpful in supporting us navigate the ICH changes a while ago.
At Aligos, we have used hERG, NaV1.5, and CaV1.2 screening routinely. Additionally, we have conducted long-term incubation with cardiomyocytes and measured functional endpoints for selected compounds where appropriate.
I have no hesitation in recommending Metrion as a CRO for preclinical drug discovery. Everyone in the Metrion team has been a pleasure to work with – I couldn’t think of anything I would change or improve about the way they work.
Read more testimonials from Metrion customers.